Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Nanomaterials (Basel) ; 12(21)2022 Oct 22.
Artículo en Inglés | MEDLINE | ID: mdl-36364491

RESUMEN

Metal and metal oxide nanoparticles, including copper nanoparticles (CuNPs), display antimicrobial activities and are regarded as promising microorganism inhibitors. Here, we explored the antimicrobial activity of CuNPs in Escherichia coli (E. coli) using two particle sizes (20 and 60 nm) and five concentrations (1, 5, 10, 50 and 100 µg/mL). The result showed a concentration-dependent trend of bactericidal activities for both size groups, with 20 nm particles more effective than 60 nm particles at low concentrations. The membrane disruption caused by CuNPs was confirmed by electron microscopy, PI staining and protein leaking analysis. However, the results of reactive oxygen species generation and genomic DNA damage revealed that the size and concentration of CuNPs were factors affecting the induction of multiple bactericidal mechanisms simultaneously on different scales. Further results of annexin V-PI staining supported this hypothesis by showing the shifting composition of the early-, late- and non-apoptotic dead cells across the CuNP groups. Many CuNP treatment groups were rescued when four mammalian modulators-wortmannin, necrosulfonamide, Z-VAD-FMK, and SBI-0206965-were applied separately. The results suggest the possible existence of bacterial programmed cell death pathways in E. coli which could be triggered by CuNP treatments.

2.
J Neurosci ; 23(21): 7958-65, 2003 Aug 27.
Artículo en Inglés | MEDLINE | ID: mdl-12944527

RESUMEN

Diadenosine tetraphosphate (AP4A), an endogenous diadenosine polyphosphate, reduces ischemic injury in the heart. In this study, we report the potent and protective effects of AP4A in rodent models of stroke and Parkinson's disease. AP4A, given intracerebroventricularly before middle cerebral artery (MCA) ligation, reduced cerebral infarction size and enhanced locomotor activity in adult rats. The intravenous administration of AP4A also induced protection when given early after MCA ligation. AP4A suppressed terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling (TUNEL) induced by hypoxia/reperfusion in primary cortical cultures, and reduced both ischemia-induced translocation of mitochondrial cytochrome c and the increase in cytoplasmic caspase-3 activity in vivo. The purinergic P2/P4 antagonist di-inosine pentaphosphate or P1-receptor antagonist sulfonylphenyl theophylline, but not the P2-receptor antagonist suramin, antagonized the effect of AP4A, suggesting that the observed protection is mediated through an anti-apoptotic mechanism and the activation of P1- and P4-purinergic receptors. AP4A also afforded protection from toxicity induced by unilateral medial forebrain bundle injection of 6-hydroxydopamine (6-OHDA). One month after lesioning, vehicle-treated rats exhibited amphetamine-induced rotation. Minimal tyrosine hydroxylase immunoreactivity was detected in the lesioned nigra or striatum. No KCl-induced dopamine release was found in the lesioned striatum. All of these indices of dopaminergic degeneration were attenuated by pretreatment with AP4A. In addition, AP4A reduced TUNEL in the lesioned nigra 2 d after 6-OHDA administration. Collectively, our data suggest that AP4A is protective against neuronal injuries induced by ischemia or 6-OHDA through the inhibition of apoptosis. We propose that AP4A may be a potentially useful target molecule in the therapy of stroke and Parkinson's disease.


Asunto(s)
Isquemia Encefálica/prevención & control , Fosfatos de Dinucleósidos/uso terapéutico , Fármacos Neuroprotectores/uso terapéutico , Enfermedad de Parkinson Secundaria/prevención & control , Animales , Apoptosis , Presión Sanguínea , Isquemia Encefálica/patología , Isquemia Encefálica/fisiopatología , Hipoxia de la Célula , Células Cultivadas , Corteza Cerebral/irrigación sanguínea , Infarto Cerebral/prevención & control , Dopamina/metabolismo , Hipocinesia/prevención & control , Locomoción , Neuronas/citología , Neuronas/efectos de los fármacos , Oxidopamina , Enfermedad de Parkinson Secundaria/inducido químicamente , Enfermedad de Parkinson Secundaria/patología , Ratas , Receptores Purinérgicos/metabolismo , Flujo Sanguíneo Regional , Accidente Cerebrovascular/fisiopatología
3.
J Psychiatr Ment Health Nurs ; 12(4): 447-55, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16011500

RESUMEN

In recent years the suicide rates have been increasing gradually in many countries. In order to reduce the number of suicides, further research on suicide and the nursing care of suicidal people is required to enhance and advance the quality of suicide nursing care provided. Statistical evidence shows that the most common method of completing suicide in many countries is hanging. Other evidence demonstrates that some suicides could be prevented if all patients were assessed for suicide risk and if psychiatric nurses provided effective nursing care, which centres on therapeutic communication skills. This paper explores the literature on suicide and on the nursing care of people who are suicidal, and also on the importance of integrating theory with practice.


Asunto(s)
Trastornos Mentales , Enfermería Psiquiátrica/organización & administración , Prevención del Suicidio , Suicidio , Adolescente , Adulto , Anciano , Actitud del Personal de Salud , Competencia Clínica , Comunicación , Femenino , Conocimientos, Actitudes y Práctica en Salud , Humanos , Masculino , Trastornos Mentales/etnología , Trastornos Mentales/enfermería , Persona de Mediana Edad , Rol de la Enfermera , Relaciones Enfermero-Paciente , Evaluación en Enfermería , Investigación en Evaluación de Enfermería , Teoría de Enfermería , Prevención Primaria , Enfermería Psiquiátrica/educación , Calidad de la Atención de Salud/organización & administración , Medición de Riesgo , Factores de Riesgo , Suicidio/etnología , Suicidio/estadística & datos numéricos , Taiwán/epidemiología
4.
J Psychiatr Ment Health Nurs ; 12(3): 275-82, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15876233

RESUMEN

Suicide is a major mental health problem in Taiwan. Estimations revealed that approximately 41% of people who committed suicide had a previous history of psychiatric inpatient care. To date, a suicide nursing care theory has not been developed. Consequently, the aim of this study was to formulate a suicide nursing care theory with the aim of enhancing and advancing the nursing care provided to people who attempt suicide or have suicidal thoughts. A qualitative approach using grounded theory was adopted. A total of 15 peoples who had either suicidal ideas or had attempted suicide and 15 psychiatric nurses were interviewed and observed. Data were analysed using open, axial and selective coding and the NUD*IST software program. A substantive theory of suicide nursing care was developed from the emergent findings. Four categories surfaced in the nursing care theory relating to the nurses' 'action/interaction strategies'. They were: the holistic assessment of people who are suicidal; providing protection; providing basic care; and providing advanced care. The findings from this study could be used to influence and advance nurse education and training, clinical practice, management and further research.


Asunto(s)
Relaciones Enfermero-Paciente , Servicio de Psiquiatría en Hospital , Prevención del Suicidio , Intento de Suicidio/prevención & control , Adolescente , Adulto , Estudios Transversales , Femenino , Grupos Focales , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Evaluación en Enfermería , Teoría de Enfermería , Admisión del Paciente/estadística & datos numéricos , Planificación de Atención al Paciente , Servicio de Psiquiatría en Hospital/estadística & datos numéricos , Suicidio/psicología , Suicidio/estadística & datos numéricos , Intento de Suicidio/psicología , Intento de Suicidio/estadística & datos numéricos , Taiwán
5.
Synapse ; 43(1): 86-94, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11746737

RESUMEN

The delta opioid peptide [D-Ala(2),D-Leu(5)]enkephalin (DADLE) has been shown to promote organ survival and to protect against methamphetamine-induced neurodegeneration. However, the cellular mechanisms of these actions of DADLE are not totally clear. We examined the action of DADLE in serum-deprived pheochromocytoma cells (PC12) and found that DADLE protected against cell death in those cells. However, the dose-response curves of the protective effects of DADLE are U-shaped as judged by three biochemical or morphological assays: the LDH release, the DNA laddering, and the apoptotic nuclei. It was found that femtomolar to picomolar concentrations of DADLE are antiapoptotic, whereas micormolar concentrations of DADLE are cytotoxic in PC12 cells. The protective effect of DADLE could be attenuated by a selective delta2 opioid antagonist and the cytotoxic action of DADLE was reduced by a selective mu opioid receptor antagonist. The treatment of cells with PD98059, a selective inhibitor of ERK kinase (MEK), or the transfection of cells with a dominant interfering form of MEK (MEK-KA97) blocked both the protective effect of DADLE and the ERK phosphorylation induced by DADLE. Cytotoxic concentrations of DADLE, on the other hand, caused an increase of Fas-ligand (FasL) in PC12 cells that was attenuated by a selective mu antagonist. Our results suggest, therefore, that endogenous opioid peptides may, at low concentrations, promote cell survival via the MEK-ERK pathway perhaps through delta2 opioid receptors, whereas they may kill cells at high concentrations via the activation of FasL through an as-yet unknown mechanism involving mu opioid receptors.


Asunto(s)
Apoptosis/efectos de los fármacos , Sistema Nervioso Central/efectos de los fármacos , Citotoxinas/farmacología , Leucina Encefalina-2-Alanina/farmacología , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Animales , Apoptosis/fisiología , Sistema Nervioso Central/metabolismo , Medio de Cultivo Libre de Suero/farmacología , Fragmentación del ADN/efectos de los fármacos , Fragmentación del ADN/fisiología , ADN de Cadena Simple/efectos de los fármacos , ADN de Cadena Simple/metabolismo , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/farmacología , Proteína Ligando Fas , Vectores Genéticos , Inmunohistoquímica , L-Lactato Deshidrogenasa/metabolismo , Glicoproteínas de Membrana/efectos de los fármacos , Glicoproteínas de Membrana/metabolismo , Quinasas de Proteína Quinasa Activadas por Mitógenos/antagonistas & inhibidores , Quinasas de Proteína Quinasa Activadas por Mitógenos/genética , Quinasas de Proteína Quinasa Activadas por Mitógenos/metabolismo , Proteínas Quinasas Activadas por Mitógenos/antagonistas & inhibidores , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Antagonistas de Narcóticos/farmacología , Neuronas/metabolismo , Células PC12 , Ratas , Receptores Opioides/metabolismo , Transfección , Receptor fas/efectos de los fármacos , Receptor fas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA